OrbiMed Fund II raises $307 mln
OrbiMed said May 23 that it second Israel-focused VC fund closed with about $307 million in capital commitments. OrbiMed Israel Partners II will target all stages and sectors of the healthcare industry, with a focus on biopharmaceuticals, digital health, medical devices, and diagnostics companies in Israel. Where appropriate, Israel Partners II may co-invest with OrbiMed’s global private equity team.
24 May 2016•2 mins read
